RNXT
RenovoRx Inc
1.60$
+1.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -0.19 | -0.20 | -0.33 | -0.49 | -0.50 | -0.39 | -0.31 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.00 | 0.00 | 0.01 | 0.04 | 0.05 | 0.05 | 0.04 | |
| 0.00 | 0.00 | 0.00 | – | – | – | – | |
| 0.03 | -0.02 | -0.01 | 0.02 | 0.03 | 0.01 | -0.01 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.00 | 0.00 | 0.00 | -0.11 | 0.10 | 0.00 | 0.00 | |
| 0.18 | 0.18 | 0.11 | 0.00 | – | – | – | |
| 0.18 | 0.18 | 1.08 | 0.00 | 0.24 | 0.64 | 0.31 | |
| -0.19 | -0.02 | 0.75 | -0.60 | -0.16 | 0.25 | 0.00 | |
| -0.19 | -0.20 | -0.33 | -0.49 | -0.50 | -0.39 | -0.31 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.